In murine breast-to-brain metastasis models, the combination of BLZ945, an inhibitor of CSF1R, and AC4-130, an inhibitor of CSF2Rb-STAT5 signaling, has proven effective in controlling tumor growth, normalizing of microglia activation states, and mitigating neuronal damage 183. Here, CSF1R is linked to neoplasm.